Beijing's Sinovac Receives Separate Approvals To Market Swine Flu Defense In Mexico, Avian Flu Vaccine In Hong Kong
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - In a breakthrough in the Chinese company's drive to become a global vaccine player, Beijing-based Sinovac Biotech has received approval to distribute its swine influenza vaccine in Mexico and its avian flu vaccine in Hong Kong